Hubro Therapeutics

    OverviewSuggest Edit

    Hubro Therapeutics is a company that develops immunotherapies for the treatment of cancer. It focuses on neoantigen targeted cancer vaccines for the activation of anti-cancer specific T cell immune responses. The company provides Framutide, a peptide vaccine corresponding to a fragment of the neo-antigen expressed by cancer cells having a frameshift mutation in the transforming growth factor b receptor 2 (TGFbR2) gene.
    TypePrivate
    Founded2018
    HQOslo, NO
    Websitehubrotherapeutics.com

    Locations

    Hubro Therapeutics is headquartered in
    Oslo, Norway

    Location Map

    Latest Updates

    Employees (est.) (Apr 2020)3
    Cybersecurity ratingAMore

    Hubro Therapeutics Office Locations

    Hubro Therapeutics has an office in Oslo
    Oslo, NO (HQ)
    red building, Ullernchausseen 64
    Show all (1)

    Hubro Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    2018

    Hubro Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    A

    96/100

    SecurityScorecard logo

    Hubro Therapeutics Online and Social Media Presence

    Embed Graph

    Hubro Therapeutics Frequently Asked Questions

    • When was Hubro Therapeutics founded?

      Hubro Therapeutics was founded in 2018.

    • How many employees does Hubro Therapeutics have?

      Hubro Therapeutics has 3 employees.

    • Who are Hubro Therapeutics competitors?

      Competitors of Hubro Therapeutics include Rakuten Medical, Alligator Bioscience and RAPT Therapeutics.

    • Where is Hubro Therapeutics headquarters?

      Hubro Therapeutics headquarters is located at red building, Ullernchausseen 64, Oslo.

    • Where are Hubro Therapeutics offices?

      Hubro Therapeutics has an office in Oslo.

    • How many offices does Hubro Therapeutics have?

      Hubro Therapeutics has 1 office.